260 related articles for article (PubMed ID: 20927050)
1. Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
Sousa VC; Assaife-Lopes N; Ribeiro JA; Pratt JA; Brett RR; Sebastião AM
Neuropsychopharmacology; 2011 Jan; 36(2):472-87. PubMed ID: 20927050
[TBL] [Abstract][Full Text] [Related]
2. Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum.
Selley DE; Cassidy MP; Martin BR; Sim-Selley LJ
Mol Pharmacol; 2004 Nov; 66(5):1275-84. PubMed ID: 15286206
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
Wise LE; Thorpe AJ; Lichtman AH
Neuropsychopharmacology; 2009 Aug; 34(9):2072-80. PubMed ID: 19322169
[TBL] [Abstract][Full Text] [Related]
4. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
Hoffman AF; Laaris N; Kawamura M; Masino SA; Lupica CR
J Neurosci; 2010 Jan; 30(2):545-55. PubMed ID: 20071517
[TBL] [Abstract][Full Text] [Related]
5. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid CB(1) and adenosine A(1) receptors independently inhibit hippocampal synaptic transmission.
Serpa A; Ribeiro JA; Sebastião AM
Eur J Pharmacol; 2009 Nov; 623(1-3):41-6. PubMed ID: 19782066
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
[TBL] [Abstract][Full Text] [Related]
8. Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline.
Varvel SA; Anum E; Niyuhire F; Wise LE; Lichtman AH
Psychopharmacology (Berl); 2005 Mar; 178(2-3):317-27. PubMed ID: 15322725
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of THC and caffeine on working memory in rats.
Panlilio LV; Ferré S; Yasar S; Thorndike EB; Schindler CW; Goldberg SR
Br J Pharmacol; 2012 Apr; 165(8):2529-38. PubMed ID: 21699509
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal inhibition of G-protein signaling is induced by CB(1) cannabinoid and GABA(B) receptor interactions in rat hippocampal membranes.
Cinar R; Freund TF; Katona I; Mackie K; Szucs M
Neurochem Int; 2008 Jun; 52(8):1402-9. PubMed ID: 18407377
[TBL] [Abstract][Full Text] [Related]
12. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Hoffman AF; Oz M; Yang R; Lichtman AH; Lupica CR
Learn Mem; 2007; 14(1-2):63-74. PubMed ID: 17202425
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.
Puighermanal E; Marsicano G; Busquets-Garcia A; Lutz B; Maldonado R; Ozaita A
Nat Neurosci; 2009 Sep; 12(9):1152-8. PubMed ID: 19648913
[TBL] [Abstract][Full Text] [Related]
14. The interactive role of CB(1) and GABA(B) receptors in hippocampal synaptic plasticity in rats.
Nazari M; Komaki A; Karamian R; Shahidi S; Sarihi A; Asadbegi M
Brain Res Bull; 2016 Jan; 120():123-30. PubMed ID: 26611204
[TBL] [Abstract][Full Text] [Related]
15. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
16. Chronic and acute adenosine A
Mouro FM; Batalha VL; Ferreira DG; Coelho JE; Baqi Y; Müller CE; Lopes LV; Ribeiro JA; Sebastião AM
Neuropharmacology; 2017 May; 117():316-327. PubMed ID: 28235548
[TBL] [Abstract][Full Text] [Related]
17. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors.
Savinainen JR; Saario SM; Niemi R; Järvinen T; Laitinen JT
Br J Pharmacol; 2003 Dec; 140(8):1451-9. PubMed ID: 14623770
[TBL] [Abstract][Full Text] [Related]
18. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
[TBL] [Abstract][Full Text] [Related]
19. Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats.
Moore NL; Greenleaf AL; Acheson SK; Wilson WA; Swartzwelder HS; Kuhn CM
J Pharmacol Exp Ther; 2010 Nov; 335(2):294-301. PubMed ID: 20668056
[TBL] [Abstract][Full Text] [Related]
20. The combined inhibitory effect of the adenosine A1 and cannabinoid CB1 receptors on cAMP accumulation in the hippocampus is additive and independent of A1 receptor desensitization.
Serpa A; Correia S; Ribeiro JA; Sebastião AM; Cascalheira JF
Biomed Res Int; 2015; 2015():872684. PubMed ID: 25667928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
